ENTITY
BeOne Medicines

BeOne Medicines (6160 HK)

502
Analysis
Health Care • Switzerland
BeOne Medicines is a global oncology biotechnology company focused on the discovery, development, and commercialization of cancer medicines. Its portfolio includes commercial-stage products like BRUKINSA, TEVIMBRA, and PARTRUVIX, which target various blood cancers and solid tumors. The company was founded in 2010 and is headquartered in Basel, Switzerland.
more
Company Event • 05 Nov 2026 21:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 14 Sep 2026 23:30 • Latest

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 31 Aug 2026 21:30 • Upcoming
Add To Calendar

Q2 2026

Company Event • 05 Aug 2026 20:00

Q2 2026

Company Event • 08 Jun 2026 22:00

Goldman Sachs 47th Annual Global Healthcare Conference 2026

x